CM
Caption Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,383
| Closed | -$115K | – | 633 |
|
|
2025
Q1 | $115K | Sell |
3,383
-22,172
| -87% | -$755K | ﹤0.01% | 435 |
|
|
2024
Q4 | $1.01M | Buy |
25,555
+24,955
| +4,159% | +$982K | 0.01% | 204 |
|
|
2024
Q3 | $28.2K | Sell |
600
-23,539
| -98% | -$1.11M | ﹤0.01% | 393 |
|
|
2024
Q2 | $1.3M | Buy |
+24,139
| New | +$1.3M | 0.02% | 118 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 526 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 555 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 515 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 451 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 464 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 527 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 604 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 583 |
|
|
2022
Q1 | – | Sell |
-13,600
| Closed | -$1.03M | – | 626 |
|
|
2021
Q4 | $1.03M | Buy |
+13,600
| New | +$1.03M | 0.01% | 259 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 615 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 511 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 459 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 405 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 379 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 375 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 346 |
|
|
2018
Q4 | – | Sell |
-5,000
| Closed | -$221K | – | 229 |
|
|
2018
Q3 | $221K | Hold |
5,000
| – | – | 0.01% | 161 |
|
|
2018
Q2 | $294K | Buy |
+5,000
| New | +$294K | 0.02% | 129 |
|